Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds
by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim
Updated on: July 19,2024
0

Subcutaneous therapy improves inflammatory bowel disease treatment, clinical trial finds
by Melissa Rohman,Northwestern UniversityLinear scale mean (SD) serum infliximab concentrations up to week 54 (PK population) in the CD (A) and UC (B) studies. Concentrations below the lower lim
Updated on:July 19,2024
0
